Jump to content
RemedySpot.com

Pharmasset Announces Issuance of U.S. Patent for PSI-7977

Rate this topic

Guest guest

By Guest guest
in Health, Medicine and Natural Healing 11

 Share

Recommended Posts

Guest guest

Guest guest

Posted
Posted

Pharmasset Announces Issuance of U.S. Patent for PSI-7977

From the PharmaLive.com News Archive - Jun. 22, 2011

Pharmasset announces that the United States Patent and Trademark Office has

issued U.S. patent 7,964,580 ( " the '580 patent " ) titled " Nucleoside

Phosphoramidate Prodrugs " . This patent generally relates to the composition of

matter of PSI-7977 and its diastereomeric mixture for the treatment of

hepatitis C virus (HCV). PSI-7977, a uracil nucleotide analogue polymerase

inhibitor of HCV, is being studied in multiple phase 2 trials.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
 Share
Go to topic listing
×
×
  • Create New...